These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders. Kilinc M; Creson T; Rojas C; Aceti M; Ellegood J; Vaissiere T; Lerch JP; Rumbaugh G Mol Cell Neurosci; 2018 Sep; 91():140-150. PubMed ID: 29580901 [TBL] [Abstract][Full Text] [Related]
9. Genetic and environmental modulation of neurodevelopmental disorders: Translational insights from labs to beds. Homberg JR; Kyzar EJ; Scattoni ML; Norton WH; Pittman J; Gaikwad S; Nguyen M; Poudel MK; Ullmann JF; Diamond DM; Kaluyeva AA; Parker MO; Brown RE; Song C; Gainetdinov RR; Gottesman II; Kalueff AV Brain Res Bull; 2016 Jul; 125():79-91. PubMed ID: 27113433 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders. Lindy AS; Stosser MB; Butler E; Downtain-Pickersgill C; Shanmugham A; Retterer K; Brandt T; Richard G; McKnight DA Epilepsia; 2018 May; 59(5):1062-1071. PubMed ID: 29655203 [TBL] [Abstract][Full Text] [Related]
11. SYNGAP1 mutations: Clinical, genetic, and pathophysiological features. Agarwal M; Johnston MV; Stafstrom CE Int J Dev Neurosci; 2019 Nov; 78():65-76. PubMed ID: 31454529 [TBL] [Abstract][Full Text] [Related]
12. Reversibility and therapeutic development for neurodevelopmental disorders, insights from genetic animal models. Megagiannis P; Suresh R; Rouleau GA; Zhou Y Adv Drug Deliv Rev; 2022 Dec; 191():114562. PubMed ID: 36183904 [TBL] [Abstract][Full Text] [Related]
13. Sodium channel epilepsies and neurodevelopmental disorders: from disease mechanisms to clinical application. Brunklaus A; Lal D Dev Med Child Neurol; 2020 Jul; 62(7):784-792. PubMed ID: 32227486 [TBL] [Abstract][Full Text] [Related]
14. Fine Mapping of a Dravet Syndrome Modifier Locus on Mouse Chromosome 5 and Candidate Gene Analysis by RNA-Seq. Hawkins NA; Zachwieja NJ; Miller AR; Anderson LL; Kearney JA PLoS Genet; 2016 Oct; 12(10):e1006398. PubMed ID: 27768696 [TBL] [Abstract][Full Text] [Related]
15. Accelerating therapeutic development and clinical trial readiness for STXBP1 and SYNGAP1 disorders. Marotta N; Boland MJ; Prosser BL Curr Probl Pediatr Adolesc Health Care; 2024 Aug; 54(8):101576. PubMed ID: 38472035 [TBL] [Abstract][Full Text] [Related]
16. Dravet syndrome as part of the clinical and genetic spectrum of sodium channel epilepsies and encephalopathies. Mei D; Cetica V; Marini C; Guerrini R Epilepsia; 2019 Dec; 60 Suppl 3():S2-S7. PubMed ID: 31904125 [TBL] [Abstract][Full Text] [Related]
17. Deciphering MECP2-associated disorders: disrupted circuits and the hope for repair. Qiu Z Curr Opin Neurobiol; 2018 Feb; 48():30-36. PubMed ID: 28961504 [TBL] [Abstract][Full Text] [Related]
18. Annual research review: The (epi)genetics of neurodevelopmental disorders in the era of whole-genome sequencing--unveiling the dark matter. Kiser DP; Rivero O; Lesch KP J Child Psychol Psychiatry; 2015 Mar; 56(3):278-95. PubMed ID: 25677560 [TBL] [Abstract][Full Text] [Related]
19. Phenotypic profiling of mGlu Fisher NM; Gould RW; Gogliotti RG; McDonald AJ; Badivuku H; Chennareddy S; Buch AB; Moore AM; Jenkins MT; Robb WH; Lindsley CW; Jones CK; Conn PJ; Niswender CM Genes Brain Behav; 2020 Sep; 19(7):e12654. PubMed ID: 32248644 [TBL] [Abstract][Full Text] [Related]
20. Proliferation and Differentiation Deficits are a Major Convergence Point for Neurodevelopmental Disorders. Ernst C Trends Neurosci; 2016 May; 39(5):290-299. PubMed ID: 27032601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]